Generics 67

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Methylprednisolone manufacturers

67 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

67 products found

methylprednisolone

Tablets 4 mg, 8 mg, 16 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, India
Registered in
India
Available for
Licensing with supply, Distribution only
MAs for sale
India
Manufacturer #22627

Manufacturer usually replies in 4 days

methylprednisolone

Tablets 4 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
PMDA
Manufacturer #19464

Manufacturer usually replies in 2 days

methylprednisolone

Tablets 4 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Manufacturer #18850

Manufacturer usually replies in 2 days

methylprednisolone

Tablets 4 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20428

Manufacturer usually replies in 4 days

methylprednisolone

Injection 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20306

Manufacturer usually replies in 1 days

methylprednisolone

Tablets 8 mg, 16 mg, 32 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20336

Manufacturer usually replies in 4 days

methylprednisolone

Injection 40 mg, 80 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20336

Manufacturer usually replies in 4 days

methylprednisolone

Injection 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19861

Manufacturer usually replies in 3 days

methylprednisolone

Tablets for oral solution 4 mg, 8 mg, 16 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19861

Manufacturer usually replies in 3 days

methylprednisolone

Tablets 4 mg, 8 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19378

Manufacturer usually replies in 4 days

methylprednisolone

Tablets 4 mg, 8 mg, 16 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19328

Manufacturer usually replies in 1 days

methylprednisolone

Tablets 4 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19124

Manufacturer usually replies in 2 days

methylprednisolone

Injection 125 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19097

Manufacturer usually replies in 2 days

methylprednisolone

Tablets 4 mg, 8 mg, 16 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18993

Manufacturer usually replies in 1 days

methylprednisolone

Tablets 4 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18411

Manufacturer usually replies in 2 days

methylprednisolone

Tablets 16 mg, 4 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18161

Manufacturer usually replies in 2 days

methylprednisolone

Tablets, film coated 4 mg, 8 mg, 16 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17816

Manufacturer usually replies in 4 days

methylprednisolone

Tablets 4 mg, 8 mg, 16 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17798

Manufacturer usually replies in 4 days

methylprednisolone

Tablets 4 mg, 16 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18530

Manufacturer usually replies in 4 days

methylprednisolone

Tablets 4 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20488

Manufacturer usually replies in 10 days

Want to view all 67 products? Create your free account today!

Methylprednisolone Manufacturers

Methylprednisolone is a corticosteroid medication used to treat a wide range of conditions, including but not limited to skin diseases, adrenogenital syndrome, rheumatic disorders, allergies, asthma, certain cancers, and multiple sclerosis. Suppliers of methylprednisolone market it in the form of oral tablets and powders for injectable solutions. The drug has been in use for over 60 years and has become included in the World Health Organization’s list of Essential Medicines that contains the most important medications recommended for a basic health system. It is among the 150 most prescribed medications in the U.S., with more than 4 million prescriptions registered annually. Methylprednisolone is approved in over 90 countries globally. And the largest manufacturer of methylprednisolone medications is Pfizer, who was the first to develop and market the pharmaceutical. Other major producers and suppliers include companies Endo, Pharmacia, Teva, and Novartis. Methylprednisolone suppliers and distributors market both generic and trade name formulations of the drug.

How Does Methylprednisolone Work?

Methylprednisolone' immediate side effects include reduced capillary permeability, vasodilation, and leukocyte migration to inflammatory areas. Changes in gene expression caused by Methylprednisolone' binding to the glucocorticoid receptor have a variety of long-lasting consequences that might last for hours or even days. In addition to inhibiting phospholipase A2, which reduces the production of arachidonic acid derivatives, glucocorticoids also boost anti-inflammatory genes like interleukin-10 and inhibit NF-Kappa B and other inflammatory transcription factors. While greater doses of Methylprednisolone suppress the immune system, lower amounts have an anti-inflammatory effect. Long-term administration of high doses of glucocorticoids attach to the mineralocorticoid receptor, increasing sodium levels and lowering potassium levels.

Wholesale Price of Methylprednisolone

The retail prices per 100 tablets of methylprednisolone fall into an approximate range of 5,00 EUR to 15,00 EUR. The prices of Methylprednisolone medications vary depending on the concentration of active ingredients in the formulation as well as supplier and manufacturer pricing. Methylprednisolone is available for sale from various Methylprednisolone vendors at various costs. Methylprednisolone suppliers, on the whole, are in favor of patient aid initiatives. The price of Methylprednisolone is higher than that of such substitutes, owing largely to the more costly manufacturing process needed to produce it. Also, the costs of Methylprednisolone vary depending on manufacturer and supplier pricing, whether it is a generic or trade name formulation, concentration of the active ingredient in the formulation.

From Where to Get Methylprednisolone?

Making use of Pipelinepharma's worldwide B2B online marketplace for medications and other pharmaceuticals is the ideal approach to locate and acquire access to Methylprednisolone manufacturers and suppliers. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Methylprednisolone manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. Buyers are advised to buy from PipelinePharma. Finding reliable suppliers and manufacturers of particular medications like Methylprednisolone can typically be a time-consuming challenge, but with Pipelinepharma's straightforward search engine and network of tested partners, the entire process becomes much simpler. Utilizing our built-in search engine, all you have to do to begin going is start looking for potential Methylprednisolone suppliers or manufacturers. You may also use filters to narrow down your search results and look for Methylprednisolone from particular nations.

Navigating our Pharmaceutical Marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Methylprednisolone offerings can be narrowed down with filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and Methylprednisolone suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Methylprednisolone. Also, each manufacturer or supplier product description contains essential information about this substance, including clinical data, stability zones, and countries in which Methylprednisolone is already registered. Manufacturers also have special delivery terms.

Establishing Commercial Ties

Suppose you are a pharmaceutical licensing company or a distributor. In that case, you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the Methylprednisolone suppliers. This way, the marketplace allows you as a distributor to skip the process of making a list of product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Methylprednisolone manufacturers for the quality of the pharmaceutical products' dossiers and protect against the risk of possible malpractices.